Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice

Journal of Biological Regulators and Homeostatic Agents

Volumn 27, Issue 1, 2013, Pages 105-119

  Masuelli, L ^a   Benvenuto, M ^b   Fantini, M ^b   Marzocchella, L ^b   Sacchetti, P ^a   Di Stefano, E ^a   Tresoldi, I ^b   Izzi, V ^b   Bernardini, R ^b   Palumbo, C ^b   Mattei, M ^b   Lista, F ^c   Galvano, F ^d   Modesti, A ^b   Bei, Roberto ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c Army Medical and Veterinary Research Center   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Apoptosis; Breast cancer; Curcumin; Neu transgenic mice; Polyphenol

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOMA; BREAST HYPERPLASIA; BREAST TUMOR; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL POPULATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SAFETY; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IC50; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE NEU; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN 3T3; DRUG EFFECT; EXPERIMENTAL NEOPLASM; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CURCUMIN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FIBROBLASTS; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NIH 3T3 CELLS; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; RATS; RECEPTOR, ERBB-2;

MLCS; MLOWN;

EID: 84878493251     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Blows FM, Driver KE, Schmidt MK, et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and lung term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PloS Med 2010; 7:e1000279.
2. Mukai H. Targeted therapy in breast cancer: current status and future directions. Jpn J Clin Oncol 2010; 40:711-6.
3. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007; 608:1-22.
4. Palumbo C, Bei R, Procopio A, Modesti A. Molecular targets and targeted therapies for malignant mesothelioma. Curr Med Chem 2008; 15:855-67.
5. Marzocchella L, Fantini M, Benvenuto M, Masuelli L, Tresoldi I, Modesti A, Bei R. Dietary flavonoids: molecular mechanisms of action as anti- inflammatory agents. Recent Pat Inflamm Allergy Drug Discov 2011; 5:200-20.
6. Izzi V, Masuelli L, Tresoldi I, Sacchetti P, Modesti A, Galvano F, Bei R. The effects of dietary flavonoids on the regulation of redox inflammatory networks. Front Biosci 2012; 17:2396-418.
7. Chiurchiù V, Maccarrone M. Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2011; 15:2605-41.
8. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008; 269:199-225.
9. Rovero S, Amici A, Di Carlo E, et al. DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplanstable carcinomas in transgenic BALB/c mice. J Immunol 2000; 165;5133-42.
10. Bei R, Pompa G, Vitolo D, et al. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J Pathol 2001; 195:343-8.
11. Di Marco E, Pierce JH, Knicley CL, Di Fiore PP. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene. Mol Cell Biol 1990; 10:3247-52.
12. Masuelli L, Marzocchella L, Quaranta A, et al. Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling. Front Biosci 2011; 16:1060-8.
13. Bei R, Masuelli L, Moriconi E, Visco V, Moretti A, Kraus MH, Muraro R. Immune responses to all ErbB family receptors detectable in serum of cancer patients. Oncogene 1999; 18:1267-75.
14. Masuelli L, Budillon A, Marzocchella L, et al. Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α-β catenins complex and multiple ErbB receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas. J Cell Physiol 2012; 227:3344-53.
15. Masuelli L, Bei R, Sacchetti P, et al. Beta-catenin accumulates in intercalated disks of hypertrophic cardiomyopathic hearts. Cardiovasc Res 2003; 60:376-87.
16. Masuelli L, Pompa G, Fabrizi M, et al. Patients with peri-implantitis, unlike those with a healthy peri-implant microenvironment, display antibodies to more than one heat shock protein (HSP 27, HSP 65 and HSP 90) linear epitope. Eur J Inflamm 2011; 9:257-67.
17. Ingrosso G, Fantini M, Nardi A, et al. Local radiotherapy increases the level of autoantibodies to ribosomal P0 protein but not to heat shock proteins, extracellular matrix molecules and EGFR/ErbB2 receptors in prostate cancer patients. Oncol Rep 2013; 29:1167-74.
18. Masuelli L, Focaccetti C, Cereda V, et al. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors. Int J Oncol 2007; 30:381-92.
19. Martín-Oliva D, Ferrer-Martín RM, Santos AM, et al. Simultaneous cell death and upregulation of poly(ADP-ribose) polymerase-1 expression in early postnatal mouse retina. Invest Ophthalmol Vis Sci 2011; 52:7445-54.
20. Pratilas CA, Solit DB. Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug response. Clin Cancer Res 2010; 16:3329-34.
21. Eccles SA. The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology. Int J Dev Biol 2011; 55:685-96.
22. Zhuang S, Schnellmann RG. A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther 2006; 319:991-7.
23. Hong RL, Spohn WH, Hung MC. Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin Cancer Res 1999; 5:1884-91.
24. Lai HW, Chien SY, Kuo SJ, Tseng LM, Lin HY, Chi CW, Chen DR. The potential utility of curcumin in the treatment of HER-2-overexpressed breast cancer: an in vitro and in vivo comparison study with herceptin. Evid Based Complement Alternat Med 2012; 2012:486568.
25. Carroll RE, Benya RV, Turgeon DK, et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res 2011; 4:354-64.
26. Golombick T, Diamond TH, Manoharan A, Ramakrishna R. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. Am J Hematol 2012; 87:455-60.
27. Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008; 14:4491-9.
28. Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther 2010; 9:8-14.
29. Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 2009; 11:495-510.
30. Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000; 28:1303-12.